Forkhead BioTherapeutics Company
Forkhead Bio is harnessing the intrinsic capabilities of cell conversion and regeneration in order to develop transformative therapies that improve patients' lives. Our first target indication is insulin-dependent diabetes.
Industry:
Geroscience
Headquarters:
New York, New York, United States
Zip:
1-10
Founded Date:
2017-01-01
Employees Number:
1-10
Acquisitions Number:
4
Investors Number:
1000000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Seed
Last Funding Type:
Seed
Register and Claim Ownership